Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(Methylsulfonyl)benzyl alcohol is a synthetic molecule that modulates bone resorption by selectively binding to estrogen receptors. It is an orally active, non-steroidal compound that can be used for the treatment of osteoporosis and other conditions associated with bone loss. 2-(Methylsulfonyl)benzyl alcohol has been shown to have a high affinity for estrogen receptors and may also inhibit the production of prostaglandins in the brain, which are involved in Alzheimer's disease. The structure-based drug design approach was employed for optimization of this molecule.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>6-Ethynylbenzo[d]thiazole is an inhibitor of the kinase ALK5, which is a receptor for growth factor-β. This inhibition prevents the phosphorylation of the receptor and subsequent activation of downstream signaling pathways. 6-Ethynylbenzo[d]thiazole also inhibits other kinases such as TGF-β and activin. 6-Ethynylbenzo[d]thiazole has been shown to inhibit cellular proliferation in vitro by inhibiting the activity of enzymes that play a role in cell division. The compound has demonstrated inhibitory activity against a number of cell lines, including human cells and tumor cells derived from human cancer patients.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-Iodo-7-nitro-1H-indazole is a synthetic compound that can be used as a cross-coupling reaction intermediate for the synthesis of trisubstituted indazoles. It is an effective inhibitor of murine leukemia, and has been shown to have efficacy against human leukemia cells in vitro. 3-Iodo-7-nitro-1H-indazole has been shown to inhibit the growth of L1210 murine leukemia cells by inhibiting DNA synthesis and cell cycle progression.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Remogliflozin is a potent inhibitor of the activity of the enzyme sglt2, which is involved in the regulation of glucose and lipid metabolism. Remogliflozin etabonate is an orally active metabolite that has been shown to inhibit sglt2 in mice with high oral bioavailability. This metabolite can be used as a lead compound for the discovery of novel drugs for diabetes and obesity treatment.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>